SINGAPORE, April 15, 2024 (Korea Bizwire) – Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”), the upstream oil and gas company with assets in the Gulf of Thailand and the Thrace Basin of Türkiye, is pleased to announce three oil discoveries on its assets in the offshore Gulf of Thailand. Sean Guest, President and [...]
BOSTON, Apr. 10 (Korea Bizwire) — Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an expert report, Acute Myeloid Leukaemia – Global Clinical Trial Landscape, offering critical data-backed analysis of the latest developments in Acute Myeloid [...]
BOSTON, Apr. 10 (Korea Bizwire) — Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released a comprehensive research report entitled Cystic Fibrosis – Global Clinical Trial Landscape. The report presents a data-backed review of the Cystic Fibrosis [...]
Report Will Combine Data from the 2024 BPM Pulse and The Planning Survey 24 STAMFORD, Conn. and WÜRZBURG, Germany, April 10, 2024 (Korea Bizwire) – BPM Partners, the leading independent authority on business performance management (BPM/CPM/EPM), and BARC, a leading analyst firm for data & analytics and enterprise software, today announced plans to release a new research [...]
The Abdel-Mohsen lab findings shed light on how sugar molecules in the blood of people living with HIV may accelerate biological aging PHILADELPHIA, PA, April 10, 2024 (Korea Bizwire) – The Wistar Institute’s associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities in the blood that may promote biological aging and [...]
Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA and Philips Respironics have now reached final agreement on the consent decree with the DOJ and FDA. As previously stated: The consent decree primarily focuses on Philips Respironics’ business operations in the US. [...]
Ninth annual initiative recognizes 22 impactful business school researchers TAMPA, Fla., April 08, 2024 (Korea Bizwire) – AACSB International (AACSB)—the world’s largest business education alliance—announces today its 2024 Class of Influential Leaders, a group of 22 AACSB-accredited business school faculty demonstrating impact through their research. Now in its ninth year, AACSB’s Influential Leaders member spotlight program highlights the [...]
VANCOUVER, British Columbia, April 08, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced five presentations including new data from its preclinical development-stage programs at the 2024 American Association for Cancer Research (AACR) [...]
SHANGHAI, China, April 07, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (“NMPA”) has approved the supplemental new drug application (“sNDA”) for toripalimab (product code: JS001) [...]
INCHEON, Korea, April 05, 2024 (Korea Bizwire) – Samsung Bioepis Co., Ltd. today announced the initiation of Phase 3 clinical trial for SB27, the company’s proposed biosimilar referencing Keytrudai (pembrolizumab). The Phase 3 clinical trial for SB27 is a randomized, double-blind, parallel group, multicenter studyii to compare the efficacy, safety, pharmacokinetics, and immunogenicity between SB27 and Keytruda [...]